Azienda Ospedaliero-Universitaria di Bologna Policlinico di S.Orsola, Bologna, Italy.
Division of Medical Genetics, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
J Am Geriatr Soc. 2021 Mar;69(3):637-643. doi: 10.1111/jgs.16922. Epub 2020 Nov 12.
The main aim of this study was to evaluate if an individualized assisted walking program (IAWP) for hospitalized older patients could improve walking ability compared with usual geriatric care and rehabilitation.
A randomized controlled trial with an active control group, open labeled with parallel assignment was conducted between October 2018 and January 2020.
Geriatric ward.
A total of 387 hospitalized patients (≥65 years) were randomly assigned to an intervention or control (usual-care) group.
The control group received usual hospital care. The intervention group received also an IAWP.
The primary endpoint was change in walking ability from hospital admission (considering both current and pre-admission status) to discharge, as assessed with the Braden Activity subscale measures. The secondary endpoint was the occurrence of in-hospital adverse events, such as complications of mobility, pressure ulcers, falls, pain and mortality, and the length of hospital stay. Intention-to-treat and per-protocol analyses were performed.
Baseline characteristics were similar between intervention and control groups. The intervention group, relative to the control group, had significantly improved walking ability at discharge (P < .001). There were no statistically significant differences between the groups in terms of in-hospital adverse events. No adverse effects were detected.
In in-hospital patients aged 65 and older, an IAWP improves walking ability at discharge.
本研究的主要目的是评估针对住院老年患者的个体化辅助步行计划（IAWP）是否比常规老年护理和康复更能改善步行能力。
这是一项在 2018 年 10 月至 2020 年 1 月期间进行的、采用主动对照、开放标签、平行分组的随机对照试验。
老年病房。
共有 387 名（≥65 岁）住院患者被随机分配到干预组或对照组（常规护理组）。
对照组接受常规医院护理。干预组还接受 IAWP。
主要终点是从入院到出院时步行能力的变化（同时考虑当前和入院前的状态），采用 Braden 活动子量表进行评估。次要终点是住院期间不良事件的发生，如移动并发症、压疮、跌倒、疼痛和死亡率，以及住院时间。进行意向治疗和方案分析。
干预组和对照组的基线特征相似。与对照组相比，干预组在出院时的步行能力显著提高（P<0.001）。两组在住院期间不良事件方面无统计学差异。未检测到不良反应。
在 65 岁及以上的住院患者中，IAWP 可提高出院时的步行能力。
